Generation Bio Co. (GBIO)

Generation Bio Co. Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	37.71	66.45	98.86	380.84	64.94	15.13
Short-Term Investments	183.78	197.92	185.92	0	199.44	0
Cash & Cash Equivalents	221.49	264.36	284.78	380.84	264.38	15.13
Cash Growth	-24.75%	-7.17%	-25.22%	44.05%	1647.26%	-79.80%
Receivables	0	3.96	0.4	0	0	0.45
Other Current Assets	5.36	4.29	1.84	-1.65	3.36	2.58
Total Current Assets	226.85	272.62	287.02	379.19	267.74	18.16
Property, Plant & Equipment	41.56	95.65	81.42	91.03	23.78	21.85
Long-Term Investments	16.79	5.79	0	0	0	0
Other Long-Term Assets	0.69	0.7	7.83	6.56	2.64	2.14
Total Long-Term Assets	59.03	102.14	89.25	97.59	26.42	23.98
Total Assets	285.88	374.76	376.26	476.77	294.16	42.14
Accounts Payable	1.48	2.35	0.66	2.02	0.27	2.25
Deferred Revenue	50.8	54.86	0	0	0	0
Current Debt	8.37	8.12	7.09	4.61	0	0
Other Current Liabilities	-32.34	-25.41	11.4	12.18	10.95	6.91
Total Current Liabilities	28.31	39.91	19.15	18.81	11.22	9.16
Long-Term Debt	87.58	89.77	74.62	76.22	0	0
Other Long-Term Liabilities	38	41.94	0	0	14.92	15.98
Total Long-Term Liabilities	125.58	131.72	74.62	76.22	14.92	15.98
Total Liabilities	153.89	171.63	93.77	95.03	26.14	25.14
Total Debt	95.95	97.89	81.71	80.83	0	0
Debt Growth	16.49%	19.81%	1.09%	-	-	-
Retained Earnings	-645.92	-571.38	-444.77	-308.13	-188.98	-108.45
Comprehensive Income	-0.2	0.27	-0.08	0	0.01	0
Shareholders' Equity	131.99	203.13	282.49	381.75	268.01	-98.59
Net Cash / Debt	125.54	166.47	203.08	300.01	264.38	15.13
Net Cash / Debt Growth	-40.78%	-18.03%	-32.31%	13.48%	1647.26%	-79.80%
Net Cash Per Share	1.89	2.58	3.49	5.33	9.70	3.20
Working Capital	198.54	232.7	267.87	360.38	256.52	9
Book Value Per Share	1.99	3.15	4.86	6.78	9.83	-20.84

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).